AstraZeneca Says Lung Cancer Drug Trial Shows No Significant Improvement in Overall Survival
LONDON – Detailed results from one of AstraZeneca’s (NASDAQ: AZN) key lung cancer trials released on Monday showed that its […]
AstraZeneca
China Detains AstraZeneca (NASDAQ: AZN) Employees in Data, Drug-Import Probes: Bloomberg
Police in China have detained five current and former employees of AstraZeneca (NASDAQ: AZN) for questioning about potential illegal activities,
China Detains AstraZeneca (NASDAQ: AZN) Employees in Data, Drug-Import Probes: Bloomberg Read More »
AstraZeneca Threatens UK Vaccine Exit Over Deadlocked State Aid Talks, FT Reports
AstraZeneca (NASDAQ: AZN) has warned it could relocate its vaccine manufacturing site from the UK to the United States as
AstraZeneca Threatens UK Vaccine Exit Over Deadlocked State Aid Talks, FT Reports Read More »
US FDA Approves Johnson & Johnson’s Combination Therapy for a Type of Lung Cancer
On Tuesday, the U.S. Food and Drug Administration approved Johnson & Johnson’s (NYSE: JNJ) chemotherapy-free combination treatment for a type
US FDA Approves Johnson & Johnson’s Combination Therapy for a Type of Lung Cancer Read More »
AstraZeneca’s Imfinzi Receives FDA Priority Review for Small Cell Lung Cancer
On Thursday, AstraZeneca (NASDAQ: AZN) said the U.S. Food and Drug Administration (FDA) has granted its blockbuster cancer drug Imfinzi
AstraZeneca’s Imfinzi Receives FDA Priority Review for Small Cell Lung Cancer Read More »
AstraZeneca (AZN) Stock Plummets as Lung Cancer Trial Update Falls Short of Expectations
AstraZeneca PLC (NASDAQ: AZN) witnessed a dramatic 8.83% plunge in its share value on Monday following a disappointing update on
AstraZeneca (AZN) Stock Plummets as Lung Cancer Trial Update Falls Short of Expectations Read More »
